CEACAM5 and prostate cancer: For example, plasma ctRNA expression of the carcinoembryonic antigen has been used for diagnosis of early stage prostate cancer [43] and plasma TERT mRNA levels have demonstrated to be predictive of response to chemoradiotherapy in rectal cancers [44].